Serum IgG level is a predicting factor for the response to neoadjuvant chemotherapy in patients with esophageal squamous cell carcinoma
Regardless of the established oncological advantages of neoadjuvant chemotherapy for esophageal squamous cell most cancers, not all instances display profit. Therefore, predicting the response to chemotherapy earlier than therapy is fascinating. Some experiences have proven that immune elements are associated to the chemotherapy response. This research aimed to research the utility of serum IgG ranges for predicting chemotherapy response. Our...